Vanguard Group Inc Pliant Therapeutics, Inc. Call Options Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PLRX
# of Institutions
175Shares Held
65.8MCall Options Held
230KPut Options Held
746K-
Deep Track Capital, LP Greenwich, CT5.97MShares$19.6 Million3.46% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$16.4 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.63MShares$15.2 Million0.01% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.2MShares$10.5 Million1.61% of portfolio
-
Chi Advisors LLC New York, NY3.01MShares$9.92 Million25.76% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $160M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...